• Home
  • News
  • Portfolio News
  • TetraGenetics and ModiQuest Collaborating for the Discovery of Therapeutic Antibodies Against KCa3.1

TetraGenetics and ModiQuest Collaborating for the Discovery of Therapeutic Antibodies Against KCa3.1

07Dec

TetraGenetics and ModiQuest Collaborating for the Discovery of Therapeutic Antibodies Against KCa3.1

Portfolio News

TetraGenetics, a biopharmaceutical company developing novel therapeutics for autoimmune diseases, today announced a collaboration with ModiQuest Research, a Dutch biotechnology company with a suite of technologies for the discovery and optimization of monoclonal antibodies including those directed against difficult target antigens with low immunogenicity. Read more >>

Share this post

Related Posts

15Nov

Carbonite Launching Disaster Recovery as a Service (DRaaS) in 2018

Carbonite is preparing to launch a disaster recovery as a service (DRaaS) platform in the first half of 2018, according... read more
09Sep

Canvas GFX and Aras partner to deliver integration of Aras Innovator and Canvas Envision

Canvas GFX, Inc, the leading provider of visual communication solutions to the manufacturing and technical industries today announced that it... read more
02Mar

How a Canned Wine Brand Sells Through Story with Marian Leitner, Founder of Archer Roose Wines

Marian Leitner is founder and CEO of Archer Roose Wines, one of the leading canned wine companies in the US.... read more
06Sep

How Amazon’s cloud business generates billions in profit

...One competing cloud storage provider is privately held Wasabi. Rather than offering a huge range of services like AWS, Wasabi... read more
29Feb

EXCLUSIVE: 4 assistive technologies for those with low vision

Roland Mattern, Director of Marketing for eSight by Gentex, discusses some assistive technologies that are enabling people with vision loss... read more
23Nov

Skyline Medical (SKLN) Reports Approval in Canada to Market STREAMWAY System

Skyline Medical Inc. (NASDAQ: SKLN) announces that it has received a Medical Device Establishment License to sell the STREAMWAY System... read more
26Jul

Myomo Expands Management Team to Accelerate Commercialization of MyoPro® Powered Orthosis

Myomo®, Inc. (NSYE MKT: MYO), a commercial stage medical robotics company, today announced the expansion of its management team with... read more
29Nov

View from the Hill: Legally blind WKU student thankful for opportunities

On this Thanksgiving, a WKU senior who is legally blind is especially thankful for not one but two additions that... read more
16Sep

RevBio Receives Approval from the U.K.’s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial

RevBio, Inc., announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom... read more
22Nov

Medical Robotics Firm Myomo Explores Going Public

Myomo, Inc., a commercial-stage medical robotics company whose products enable users to overcome upper extremity paralysis (www.myomo.com), announced today that... read more